Join this Featured Workgroup!
Elite Investors

This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.

In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.

In your application messsage, please share your background and what you can contribute to the group.



Company Overview and News

0
Nestle India market cap crosses Rs 1 lakh cr

2018-07-17 moneycontrol
FMCG major Nestle India's market valuation has surged past Rs 1 lakh crore mark helped by a rally in its share price. The company's market valuation stood at Rs 1,01,541.66 crore at close of trade on BSE today.
500696 NESTLEIND HINDUNILVR NSZTY 500790

1
Q1 Results 2018: What to expect

2018-07-08 livemint
Mumbai: Listed companies, barring telecom firms and select banks, are expected to post decent earnings growth in the June quarter (Q1), helped by rising consumption and the low base of last year, various broking companies said. The falling rupee has helped exporters as well.
500825 500820 509480 DABUR BRTQY HINDUNILVR ASIANPAINT DBRQY 532215 EQMNY 500096 PIDILITIND 532187 PDLTY AXISBANK 500696 HDFCBANK 500790 BRITANNIA NSZTY 500331 BERGEPAINT AXB INDUSINDBK IBN NESTLEIND AXBKY AXBA ICICIBANK 532210 HDB 532174 500180 CUB

2
Nestle enters packaged breakfast market with Nesplus

2018-07-02 livemint
New Delhi: Nestlé India Ltd, the maker of Maggi instant noodles, on Monday entered the packaged breakfast market in India with the launch of Nesplus. The company hopes to crack a market where a majority of the 1.3 billion people still prefer freshly-made, Indian breakfast.
GIS NESTLEIND NSZTY 500790

15
Decoding: The millennial consumer

2018-06-25 livemint
New Delhi: Sulagna Dasgupta, 26, does not remember when she last visited a brick-and-mortar retail store. Definitely not for the past two years, when she moved from Kolkata to New Delhi to work with one of the country’s top publishing firms. Indeed, Dasgupta prefers to buy everything—from clothes to cosmetics—online, because “it’s convenient and cheaper”.
HGRL DABUR MS.PRE MS.PRF NESTLEIND MS.PRG MS.PRA DBRQY 532424 GDRJY 500096 MS.PRI PEP MS.PRK MS GODREJCP 500790 NSZTY

21
Market Live: Sell-off continues on trade tensions; all sectoral indices in the red

2018-06-19 moneycontrol
Oil Prices Update: Oil prices fell nearly one percent as an escalating trade dispute between the United States and China triggered sharp selloffs in many global markets.
LIBERTSHOE 523768 500325 GOACARBON GUJBOROS RELIANCE GLKQY 539437 500470 IDFCBANK RIGD 500790 NSZTY RLNIY 509567 SBAZ GLENMARK IBN 502219 TATAPOWER NESTLEIND HEXAWARE 539302 532129 POWERMECH BOROSIL ICICIBANK TTST 532296 TATASTEEL TATLY 532174 TPCL 500400 526596

36
Market Live: Sensex extends losses amid trade war woes; IOC, HPCL, BPCL dip 3%

2018-06-19 moneycontrol
Glenmark Pharmaceuticals announced that the US Food & Drug Administration provided its first supplemental abbreviated new drug application (sANDA) approval for the company’s manufacturing facility in Monroe, North Carolina.
LIBERTSHOE 523768 500325 GUJBOROS RELIANCE KAJARIACER 532418 BHRQY GLKQY 532215 JUSTDIAL CMQMY 500470 535648 533407 AXISBANK RIGD 500233 CUMMINSIND BHARTIARTL 500790 NSZTY RLNIY SBAZ GLENMARK AXB 502219 IBN NESTLEIND HEXAWARE 539302 532129 AXBKY POWERMECH 532454 BOROSIL AXBA 500480 ICICIBANK TTST 532296 TATASTEEL TATLY 532174 CNOVAPETRO 526596 JSTQY ANDHRABANK

3
FMCG stocks: MNC players beat domestic peers on returns front

2018-06-04 thehindubusinessline
Priya Kansara FMCG stocks have been giving robust returns in the last decade with their market capitalisation (₹1,000 crore and above) jumping seven-fold, according to data provided by Capitaline. This has been led by MNC stocks, which have done better than domestic FMCG companies, with market-cap jumping 6.5 times and six times, respectively.
500825 DABUR BRTQY GSKCONS NESTLEIND HINDUNILVR DBRQY 532424 GDRJY 500096 507815 GILLETTE 500696 GODREJCP 500676 500790 BRITANNIA NSZTY

0
Ferrero may bring brands it acquired from Nestle’s US unit to India

2018-05-29 livemint
New Delhi: Ferrero India Pvt. Ltd, the local unit of Italy-headquartered Ferrero Group, may expand its product offerings for the Indian market with the launch of 20 new confectionery brands, which it had acquired from the US unit of Swiss packaged goods company Nestle SA in January.
NESTLEIND 1470 NSZTY 500790

0
Patanjali sales growth grinds to a halt in FY18

2018-05-18 livemint
New Delhi: Patanjali Ayurved Ltd’s scorching pace of growth, which had left rival packaged goods companies scurrying to defend their turf over the past few years, has stalled, with Baba Ramdev’s company saying sales was little changed in the year ended 31 March.
500696 NESTLEIND HINDUNILVR NSZTY 500790

0
Most FMCG firms beat Street math in Q4

2018-05-16 thehindubusinessline
Priya Kansara The consumer sector is among the few in the economy on which analysts and investors have pinned high hopes for a strong financial performance in the March quarter. And not without reason, given the low base of the post-demonetisation period and better macro environment compared to other industries.
500820 KAJARIACER DABUR NESTLEIND HINDUNILVR 533155 ASIANPAINT DBRQY JUBLFOOD 532424 GDRJY 500096 ZEEEY JBLWY 505537 500233 500696 GODREJCP ZEEL 500790 NSZTY

0
Nestle India shares vault nearly 6% as Q1 profit jumps

2018-05-11 livemint
New Delhi: Nestle India shares on Friday jumped nearly 6% after the FMCG major reported 35.98% rise in profit for the first quarter of 2018.
NESTLEIND NSZTY 500790

Related Articles

KTOV: Kitov Pharamceuticals Holdings Analysis and Research Report

2018-07-17 - Asif

History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...

ATHX: Athersys Analysis and Research Report

2018-07-17 - Asif

Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...

CYTX: Cytori Therapeutics Analysis and Research Report

2018-07-16 - Asif

General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...